Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis

Cancer Research

Volumn 65, Issue 5, 2005, Pages 1627-1630

  Kiaris, Hippokratis ^a,b   Chatzistamou, Ioulia ^a   Trimis, George ^a   Frangou Plemmenou, Matrisa ^a   Pafiti Kondi, Agatha ^a   Kalofoutis, Anastasios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CARCINOGENICITY; CELL ISOLATION; CONTROLLED STUDY; EMBRYO; EPITHELIUM TUMOR; FEMALE; FIBROBLAST; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HOST; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LATENT PERIOD; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; STROMA; TUMOR SUPPRESSOR GENE; WILD TYPE;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FIBROBLASTS; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; LOSS OF HETEROZYGOSITY; MICE; MICE, KNOCKOUT; MICE, SCID; SEVERE COMBINED IMMUNODEFICIENCY; STROMAL CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 16444363001     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3791     Document Type: Article

References (14)

1. Hollstein M, Moeckel G, Hergenhahn M, et al. On the origins of tumor mutations in cancer genes: insights from the p53 gene. Mutat Res 1998;405:145-54.
2. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999;59:5002-11.
3. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 2002;32:355-7.
4. Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S, Watson PH, Eng C. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet 2001;10:1907-13.
5. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 2002;62:3298-307.
6. Maeda T, Alexander CM, Friedl A. Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells. Cancer Res 2004;64:612-21.
7. Kuperwasser C, Chavarria T, Wu M, et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A 2004;101:4966-71.
8. Jacks T, Remington L, Williams BO, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1-7.
9. Urano T, Saito T, Tsukui T, et al. Efp targets 14-3-3 σ for proteolysis and promotes breast tumour growth. Nature 2002;417:871-75.
10. Schuler T, Kornig S, Blankenstein T. Tumor rejection by modulation of tumor stromal fibroblasts. J Exp Med 2003;198:1487-93.
11. Nakagawa H, Liyanarachchi S, Davuluri RV, et al. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 2004;44:7366-77.
12. Nakamura N, Iijima T, Mase K, et al. Phenotypic differences of proliferating fibroblasts in the stroma of lung adenocarcinoma and normal bronchus tissue. Cancer Sci 2004;95:226-32.
13. Tlsty TD, Hein PW. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001;11:54-9.
14. Nacht M, Strasser A, Chan YR, et al. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev 1996;10:2055-66.